Let-7a-5p abrogates progression of papillary thyroid carcinoma cells by decreasing nuclear receptor subfamily 6 group...

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, with many underlying molecular mechanisms yet to be fully understood.
• MicroRNAs (miRNAs) play crucial roles in the development and progression of various cancers, including PTC.

Purpose of the Study:

• To investigate the role of let-7a-5p in PTC progression.
• To identify the molecular targets and pathways regulated by let-7a-5p in PTC.
• To evaluate the therapeutic potential of targeting the let-7a-5p/NR6A1 axis in PTC.

Main Methods:

• Bioinformatic analysis and open-access database mining to identify potential miRNA roles.
• Lentivirus-mediated overexpression of let-7a-5p in PTC cells.
• Luciferase reporter assays and quantitative reverse transcription polymerase chain reaction (qRT-PCR) for target validation.
• In vitro and in vivo experiments to assess the impact on lipogenesis and tumor growth.

Main Results:

• Downregulation of let-7a-5p was found to accelerate PTC progression.
• Overexpression of let-7a-5p suppressed PTC cell proliferation and invasion.
• NR6A1 was identified as a direct target gene of let-7a-5p.
• The let-7a-5p/NR6A1 interaction regulated lipogenesis in PTC cells, both in vitro and in vivo.
• let-7a-5p overexpression inhibited xenograft tumor growth and NR6A1 expression in vivo.

Conclusions:

• let-7a-5p acts as a tumor suppressor in PTC by decreasing lipogenesis.
• The let-7a-5p/NR6A1 axis represents a promising therapeutic target for papillary thyroid carcinoma treatment.